CLINICAL_TRIALS
trial_result
· 2024-02-28
Clinical Trial Update: A Study to Evaluate Multiple Oral Doses of Luvadaxistat in Adults With Schizophrenia [Phase 2]
Summary
Phase 2 study assessing multiple oral doses of luvadaxistat in adults with schizophrenia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Neurocrine Biosciences | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2024-02-28